WallStreetZenWallStreetZen

NYSEMKT: KAPA
Kairos Pharma Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Kairos Pharma earnings were -$5.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest KAPA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.4M, down 16.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KAPA reported annual earnings of -$5.4M, with 109.3% growth. The next KAPA earnings date is Nov 13, 2026.

KAPA earnings history

Current Revenue
$0.0
Current Earnings
-$5.8M
Current Profit Margin
0%

KAPA Return on Equity

Current Company
-98.8%
Current Industry
-10.8%
Current Market
30.9%
KAPA's Return on Equity (-98.8%)... subscribe to Premium to read more.
High Return on Equity Performance

KAPA Return on Assets

Current Company
-93.6%
Current Industry
-10.7%
KAPA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KAPA announces earnings.

KAPA Return on Capital Employed

Current Company
-138.51%
Current Industry
-7.4%

KAPA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KAPA-$5.66M-$5.81MN/A-$0.28
ATNM$12.18M$11.31MN/A$0.36
EDSA-$14.00M-$14.10MN/A-$1.69
MGX-$83.14M-$93.46MN/A-$2.49
BCTX-$31.35M-$31.15MN/A-$3.11
View Top Biotech Stocks

KAPA earnings dates

Next earnings date
Nov 13, 2026

Kairos Pharma Earnings Reports & History FAQ

What were Kairos Pharma's earnings last quarter?

On KAPA's earnings call on Aug 11, 2026, Kairos Pharma (NYSEMKT: KAPA) reported Q2 2026 earnings per share (EPS) of -$0.06, up 25% year over year. Total KAPA earnings for the quarter were -$1.39 million. In the same quarter last year, Kairos Pharma's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Kairos Pharma stock.

When does Kairos Pharma report earnings?

The next KAPA earnings date is Nov 13, 2026. Add KAPA to your watchlist to be reminded of Kairos Pharma's next earnings date.

Is Kairos Pharma profitable or losing money?

As of the last Kairos Pharma earnings report, Kairos Pharma is currently losing money. Kairos Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$5.81 million, a 23.22% increase year over year.

What was KAPA's earnings growth in the past year?

As of Kairos Pharma's earnings date in Aug 11, 2026, Kairos Pharma's earnings has grown year over year. KAPA earnings in the past year totalled -$5.81 million.

What are Kairos Pharma's earnings expectations?

The current EPS estimate for Kairos Pharma's earnings report in Nov 13, 2026 is -$0.63.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.